Engineered Spider Silk in Core–Shell Multifunctional Fibrous Mat for Accelerated Chronic Diabetic Wound Healing via Macrophage Polarization

Macrophage phenotypic switching from pro-inflammatory M1 to pro-regenerative M2 is impaired in chronic diabetic wounds, leading to excessive reactive oxygen species (ROS) production, poor angiogenesis, and decreased collagen deposition, thereby affecting the healing cascade. Development of multifunctional biomaterial with bioactive compounds to modulate the immune microenvironment and combat ROS, with the potential to facilitate angiogenesis and increase collagen deposition. Here, a novel combination therapy of silk DOPA-crisaborole conjugate (SDC, angiogenic and anti-inflammatory) and eugenol (Eu, antioxidant) has been devised to promote chronic wound healing. The core-shell electrospun fibrous mat has been fabricated with Eu in a polycaprolactone core (PCL-Eu) and SDC in a dextran shell (Dex-SDC), collectively termed Dex-SDC/PCL-Eu. In response to the acidic environment of chronic wounds, the dynamic benzoxaborole-catechol complex between crisaborole and silk DOPA cleaves, releasing crisaborole, while the matrix degradation of Dex-SDC/PCL-Eu over time enables the controlled release of Eu for 12 days. The initial release of crisaborole promotes polarization of M1 macrophages to M2 phenotype by significantly upregulating anti-inflammatory cytokine IL-10 and downregulating pro-inflammatory cytokine IL-6 gene expression in Dex-SDC/PCL-Eu-treated THP-1 cells compared to control. Subsequently, the sustained release of Eu mitigates oxidative damage. Dex-SDC/PCL-Eu fibers facilitate in vitro adhesion, migration, and proliferation of fibroblasts and endothelial cells as well as enhance endothelial tube formation. In the diabetic rat model, the Dex-SDC/PCL-Eu fibers reduce inflammatory granulation tissue and ulceration, while promoting neovascularization, complete re-epithelialization, and well-organized dermis and epidermis formation with uniform collagen deposition. Thus, the developed multifunctional Dex-SDC/PCL-Eu fibrous mat accelerates full-thickness skin wound healing and holds promise for the treatment of chronic diabetic wounds.

Authors

Institutions

Publication Details

Journal
ACS Biomaterials Science & Engineering
Published
2025-09-22
DOI
https://doi.org/10.1021/acsbiomaterials.5c00737
Citations
4
Primary Topic
Wound Healing and Treatments
Type
article
Field-Weighted Citation Impact
4.10
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Engineered Spider Silk in Core–Shell Multifunctional Fibrous Mat for Accelerated Chronic Diabetic Wound Healing via Macrophage Polarization

Numbi Ramudu Kamini, Janani Radhakrishnan, Niraikulam Ayyadurai, Mohandass Pachaiyappan et al.
4 citations
ACS Biomaterials Science & Engineering
Wound Healing and Treatments
4.10
article

Engineered Spider Silk in Core–Shell Multifunctional Fibrous Mat for Accelerated Chronic Diabetic Wound Healing via Macrophage Polarization

Numbi Ramudu Kamini, Janani Radhakrishnan, Niraikulam Ayyadurai, Mohandass Pachaiyappan, Mercyjayapriya Jebakumar
article en
4 citations

Abstract

Macrophage phenotypic switching from pro-inflammatory M1 to pro-regenerative M2 is impaired in chronic diabetic wounds, leading to excessive reactive oxygen species (ROS) production, poor angiogenesis, and decreased collagen deposition, thereby affecting the healing cascade. Development of multifunctional biomaterial with bioactive compounds to modulate the immune microenvironment and combat ROS, with the potential to facilitate angiogenesis and increase collagen deposition. Here, a novel combination therapy of silk DOPA-crisaborole conjugate (SDC, angiogenic and anti-inflammatory) and eugenol (Eu, antioxidant) has been devised to promote chronic wound healing. The core-shell electrospun fibrous mat has been fabricated with Eu in a polycaprolactone core (PCL-Eu) and SDC in a dextran shell (Dex-SDC), collectively termed Dex-SDC/PCL-Eu. In response to the acidic environment of chronic wounds, the dynamic benzoxaborole-catechol complex between crisaborole and silk DOPA cleaves, releasing crisaborole, while the matrix degradation of Dex-SDC/PCL-Eu over time enables the controlled release of Eu for 12 days. The initial release of crisaborole promotes polarization of M1 macrophages to M2 phenotype by significantly upregulating anti-inflammatory cytokine IL-10 and downregulating pro-inflammatory cytokine IL-6 gene expression in Dex-SDC/PCL-Eu-treated THP-1 cells compared to control. Subsequently, the sustained release of Eu mitigates oxidative damage. Dex-SDC/PCL-Eu fibers facilitate in vitro adhesion, migration, and proliferation of fibroblasts and endothelial cells as well as enhance endothelial tube formation. In the diabetic rat model, the Dex-SDC/PCL-Eu fibers reduce inflammatory granulation tissue and ulceration, while promoting neovascularization, complete re-epithelialization, and well-organized dermis and epidermis formation with uniform collagen deposition. Thus, the developed multifunctional Dex-SDC/PCL-Eu fibrous mat accelerates full-thickness skin wound healing and holds promise for the treatment of chronic diabetic wounds.

ACS Biomaterials Science & EngineeringVol. 11(10)
Central Leather Research Institute (IN), Academy of Scientific and Innovative Research (IN)
Openalex Percentile: Top 6%
Wound Healing and Treatments
4.10
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.